HopeStage
Back to all studies
CompletedNCT04505189

Psilocybin for Anorexia: Pilot Study

About this titleRead the official source — NCT04505189
Medication studyAges 21–65United KingdomEating disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 21 years to 65 years.

Listed locations
LondonSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 28, 2021
Recruitment status
Completed
Enrollment listed in the registry
21
Sponsor
Imperial College London
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United Kingdom
Age range
From 21 Years to 65 Years
Official registry ID
NCT04505189
Official title
Show the full official title

Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Imperial College London, a university.

Did this study involve medication?

Yes. The study involved medication, including Psilocybin.

Who was this study for?

Listed age limits: 21 years to 65 years.

Want to explore more studies?

Explore studies